Biocon arm gets Health Canada nod for fungal infection treatment injection
Published on: May 11, 2026, 11:03 a.m. | Source: The Economic Times
Biocon Pharma Ltd has secured Health Canada approval for its micafungin for injection. This medication targets serious fungal infections in adults and children. It will be used for conditions like candidemia and esophageal candidiasis. The approval also covers prophylaxis in stem cell transplant patients. This marks a significant addition to Biocon's product offerings.
